SINGAPORE -- Singaporean investors are plowing into startups in the health care sector, drawn by the industry's innovations and strong government support.
Biofourmis, a startup originally from Singapore which recently shifted its headquarters to Boston, is one such example. The company plans to raise $100 million to $200 million in 2021, after bagging $35 million from U.S. investment fund Sequoia India, Openspace Ventures of Singapore and the Singapore government's venture capital arm EDBI.
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)